Program masterclass 'Biologics - towards personalised medicine'

Date: Friday 14 October 2016
Location: Sanquin, Plesmanlaan 125, 1066 CX Amsterdam, the Netherlands

09:30 – 09:45 Welcome and coffee
09.50 – 10.00 Introduction Sanquin
Theo Rispens PhD, Principal Investigator at the Department of Immunopathology, Sanquin Research
10:00 – 10:40 Immunogenicity and TNF blockers
Theo Rispens PhD, Principal Investigator at the Department of Immunopathology, Sanquin Research
10:40 – 11:10 Personalised medicine for biologics: from serum to bloodspot, from trough levels to therapeutic drug monitoring
Annick de Vries PhD, Head Biologicals Laboratory at Sanquin Diagnostic Services
11:10 – 11:40 Coffee/Tea
11:40 – 12:30 Personalised dosing of natalizumab in multiple sclerosis
Joep Killestein MD PhD, Staff Neurologist at Vrije Universiteit Medical Centre and the MS Centre Amsterdam
12:30 – 13:15 Lunch break
13:15 – 13:45 Assays for therapeutic drug monitoring of infliximab
Thomas van Stappen, Research scientist at the Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium
13:45 – 14:15 Visit to the Sanquin Laboratories
14:15 – 14:35 Biosimilars analysed
Ronald Boshuizen PhD, Assay developer at the Biologicals Laboratory, Sanquin Diagnostic Services
14:35 – 15:20 Clinical relevance of immunogenicity of anti-TNF agents
Gertjan Wolbink MD PhD, Rheumatologist at the Jan van Breemen Research Institute/Reade and Senior scientist and at Department of Immunopathology, Sanquin Research
15:20 – 15:30 Closing remarks by Theo Rispens
15:30 – 16:30 Drinks with speakers + networking opportunities

 

Last edited on: 15 June 2016